Paper41279375
Regulatory T cells inhibit CD8+ TRM-like cells during the early stages of tumor immune escape.
Williams JB and 10 others. bioRxiv, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Regulatory T cells inhibit CD8+ TRM-like cells during the early stages of tumor immune escape. Papers, record 41279375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41279375
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Regulatory T cells inhibit CD8+ TRM-like cells during the early stages of tumor immune escape.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI127654 | NIAID NIH HHS | United States | R01AI127654 | PubMed and NIH | NIH RePORTER |
| R01 AR065807 | NIAMS NIH HHS | United States | R01AR065807 | PubMed and NIH | NIH RePORTER |
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34179824 | Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy. | Nat Cancer | 2021 | https://conductscience.org/library/papers/34179824 | PubMed |
| 2 | 31810882 | Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection. | Immunity | 2019 | https://conductscience.org/library/papers/31810882 | PubMed |
| 3 | 38455971 | Tissue-resident memory T cell signatures from single-cell analysis associated with better melanoma prognosis. | iScience | 2024 | https://conductscience.org/library/papers/38455971 | PubMed |
| 4 | 26688350 | Tissue-resident memory T cells: local specialists in immune defence. | Nat Rev Immunol | 2016 | https://conductscience.org/library/papers/26688350 | PubMed |
| 5 | 39142275 | Resident memory T cells and cancer. | Immunity | 2024 | https://conductscience.org/library/papers/39142275 | PubMed |
| 6 | 37607911 | Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy. | Nat Commun | 2023 | https://conductscience.org/library/papers/37607911 | PubMed |
| 7 | 25725111 | CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients. | J Immunol | 2015 | https://conductscience.org/library/papers/25725111 | PubMed |
| 8 | 30598548 | Tissue-resident memory CD8+ T cells promote melanoma-immune equilibrium in skin. | Nature | 2019 | https://conductscience.org/library/papers/30598548 | PubMed |
| 9 | 37545498 | Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy. | Front Immunol | 2023 | https://conductscience.org/library/papers/37545498 | PubMed |
| 10 | 38969523 | TCF1-positive and TCF1-negative TRM CD8 T cell subsets and cDC1s orchestrate melanoma protection and immunotherapy response. | J Immunother Cancer | 2024 | https://conductscience.org/library/papers/38969523 | PubMed |
| 11 | 24162776 | The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. | Nat Immunol | 2013 | https://conductscience.org/library/papers/24162776 | PubMed |
| 12 | 28552347 | Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation. | Cell | 2017 | https://conductscience.org/library/papers/28552347 | PubMed |
| 13 | 28486109 | Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy. | Cancer Cell | 2017 | https://conductscience.org/library/papers/28486109 | PubMed |
| 14 | 28628092 | Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer. | Nat Immunol | 2017 | https://conductscience.org/library/papers/28628092 | PubMed |
| 15 | 29769722 | Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. | Nature | 2018 | https://conductscience.org/library/papers/29769722 | PubMed |
| 16 | 28018343 | Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients. | Front Immunol | 2016 | https://conductscience.org/library/papers/28018343 | PubMed |
| 17 | 28219080 | Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. | Nature | 2017 | https://conductscience.org/library/papers/28219080 | PubMed |
| 18 | 25787765 | Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/25787765 | PubMed |
| 19 | 37392736 | Single-cell protein expression profiling resolves circulating and resident memory T cell diversity across tissues and infection contexts. | Immunity | 2023 | https://conductscience.org/library/papers/37392736 | PubMed |
| 20 | 30026331 | Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis. | Cancer Res | 2018 | https://conductscience.org/library/papers/30026331 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41869343 | Risk factors and immune landscape of early local tumor progression after microwave ablation for lung cancer: a retrospective nested case-control study. | Front Immunol | 2026 | https://conductscience.org/library/papers/41869343 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41279375
GET https://conductscience.org/api/papers/v1/41279375/references?page=2